ClinicalMetric / Countries / South Korea / ischemic stroke
← 🇰🇷 South Korea Trials
🇰🇷 South Korea Country × Condition

ischemic stroke Clinical Trials in South Korea

Active clinical trials for ischemic stroke with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇰🇷 South Korea

Active Trials in South Korea (3)

NCT07156955
Recruiting

Proprioceptive Error Correction for Post-Stroke Upper Limb Rehabilitation

Enrollment
3 pts
Country
🇰🇷 South Korea
Sungkyunkwan University
View Trial →
NCT07687706 Phase 3
Recruiting

Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)

Enrollment
1,524 pts
Country
🇰🇷 South Korea
Hanyang University Guri Hospital
View Trial →
NCT06649240
Recruiting

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

Enrollment
4,016 pts
Country
🇰🇷 South Korea
Seoul National University Hospital
View Trial →

Frequently Asked Questions

How many ischemic stroke clinical trials are active in South Korea?
There are currently 3 active clinical trials for ischemic stroke with sites in South Korea, of which 3 are actively recruiting patients.
How can I join a ischemic stroke clinical trial in South Korea?
To join a ischemic stroke clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ischemic stroke trials in South Korea?
Active ischemic stroke trials in South Korea span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All South Korea Trials → Global ischemic stroke Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology